These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26249215)

  • 21. Female sex hormone receptors in gallbladder cancer.
    Saranga Bharathi R; Singh R; Gupta R; Verma GR; Kalra N; Kiran K; Joshi K
    J Gastrointest Cancer; 2015 Jun; 46(2):143-8. PubMed ID: 25772307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Squamous/adenosquamous carcinoma of the gallbladder: Analysis of 34 cases and comparison of clinicopathologic features and surgical outcomes with adenocarcinoma.
    Song HW; Chen C; Shen HX; Ma L; Zhao YL; Zhang GJ; Geng ZM; Wang L
    J Surg Oncol; 2015 Nov; 112(6):677-80. PubMed ID: 26458491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of CD109 expression in myxofibrosarcoma.
    Emori M; Tsukahara T; Murata K; Sugita S; Sonoda T; Kaya M; Soma T; Sasaki M; Nagoya S; Hasegawa T; Wada T; Sato N; Yamashita T
    J Surg Oncol; 2015 Jun; 111(8):975-9. PubMed ID: 26031650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic analysis of adenosquamous/squamous cell carcinoma of the gallbladder.
    Kim WS; Jang KT; Choi DW; Choi SH; Heo JS; You DD; Lee HG
    J Surg Oncol; 2011 Mar; 103(3):239-42. PubMed ID: 21337551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.
    Li J; Yang Z; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
    Clin Transl Oncol; 2014 Feb; 16(2):200-7. PubMed ID: 23793810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EphB1 and Ephrin-B, new potential biomarkers for squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder.
    Yuan Y; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF; Zeng GX; Chen SL
    Asian Pac J Cancer Prev; 2014; 15(3):1441-6. PubMed ID: 24606480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatopancreatoduodenectomy for squamous and adenosquamous carcinoma of the gallbladder.
    Miyazaki K; Tsutsumi N; Kitahara K; Mori M; Sasatomi E; Tokunaga O; Hisatsugu T
    Hepatogastroenterology; 1995 Feb; 42(1):47-50. PubMed ID: 7782034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Proteomic study of gallbladder cancer, with special reference on the expression and significance of annexin A3].
    Tan Y; Meng HP; Wu Q; Wang FQ; Wu HR
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):382-6. PubMed ID: 21055154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
    Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
    Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosquamous/squamous cell carcinoma of the gallbladder.
    Chan KM; Yu MC; Lee WC; Jan YY; Chen MF
    J Surg Oncol; 2007 Feb; 95(2):129-34. PubMed ID: 17262729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
    Li J; Yang ZL; Ren X; Zou Q; Yuan Y; Liang L; Chen M; Chen S
    Tumour Biol; 2013 Feb; 34(1):359-68. PubMed ID: 23065574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
    Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
    Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD109 expression in squamous cell carcinoma of the uterine cervix.
    Zhang JM; Hashimoto M; Kawai K; Murakumo Y; Sato T; Ichihara M; Nakamura S; Takahashi M
    Pathol Int; 2005 Apr; 55(4):165-9. PubMed ID: 15826242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
    Zhou S; da Silva SD; Siegel PM; Philip A
    Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamous variant of gallbladder cancer: is it different from adenocarcinoma?
    Kalayarasan R; Javed A; Sakhuja P; Agarwal AK
    Am J Surg; 2013 Sep; 206(3):380-5. PubMed ID: 23827515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.
    Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M
    Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CD109 in human cancer.
    Hashimoto M; Ichihara M; Watanabe T; Kawai K; Koshikawa K; Yuasa N; Takahashi T; Yatabe Y; Murakumo Y; Zhang JM; Nimura Y; Takahashi M
    Oncogene; 2004 Apr; 23(20):3716-20. PubMed ID: 15116102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosquamous carcinoma of the gallbladder: a rare entity and dilemmas in its management.
    Zishan MA; Tee CL
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37236675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.
    Jia W; Ren C; Wang L; Zhu B; Jia W; Gao M; Zeng F; Zeng L; Xia X; Zhang X; Fu T; Li S; Du C; Jiang X; Chen Y; Tan W; Zhao Z; Liu W
    Oncotarget; 2016 Aug; 7(34):55328-55342. PubMed ID: 27419372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expressions of Ep-CAM and cyclin D1 and their clinical significance in gallbladder carcinoma].
    Ren G; Yu G; Liu LW; Ma L
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):841-4. PubMed ID: 20137349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.